BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 3071518)

  • 1. [A study on reversion of the human activated c-Ha-ras-transformed cells].
    Ogiso Y
    Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Involvement of cAMP dependent protein kinase in the reversion of a NIH/3T3 cell line transformed by a ras oncogene (EJ-NIH/3T3)].
    Oda A
    Hokkaido Igaku Zasshi; 1988 Sep; 63(5):747-53. PubMed ID: 3071519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
    Storer RD; Allen HL; Kraynak AR; Bradley MO
    Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat embryo cells immortalized with transfected oncogenes are transformed by gamma irradiation.
    Endlich B; Salavati R; Sullivan T; Ling CC
    Radiat Res; 1992 Dec; 132(3):301-11. PubMed ID: 1475353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of a specific protein in flat revertant cell lines derived from ras oncogene-transformed cells].
    Fujita H
    Hokkaido Igaku Zasshi; 1990 Mar; 65(2):210-20. PubMed ID: 2194920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
    Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
    J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfection of EK-3, a subline of NIH 3T3, with the oncogene Ha-ras does not abolish its anchorage dependence.
    Katz E; Samid D
    Eur J Cell Biol; 1989 Aug; 49(2):221-4. PubMed ID: 2673787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
    Kuo ML; Chou YW; Chau YP; Huang TS
    Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of normal homologous cells by a spontaneously activated Ha-ras oncogene.
    Schwartz SA; Shuler CF; Freebeck P
    Cancer Res; 1988 Jun; 48(12):3470-7. PubMed ID: 3285996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on alterations of gene expression in a flat revertant R1 from ras-oncogene transformed NIH/3T3 cells].
    Müllauer L
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):705-16. PubMed ID: 7693563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
    Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
    Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
    Omata-Yamada T; Yamada H; Lengyel P
    J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
    Lebeau J; Le Chalony C; Prosperi MT; Goubin G
    Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.
    Pratt CI; Kao CH; Wu SQ; Gilchrist KW; Oyasu R; Reznikoff CA
    Cancer Res; 1992 Feb; 52(3):688-95. PubMed ID: 1310069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigens expressed on NIH 3T3 cells following transformation with DNA from human pancreatic tumor.
    Hollingsworth MA; Rebellato LM; Moore JW; Finn OJ; Metzgar RS
    Cancer Res; 1986 May; 46(5):2482-7. PubMed ID: 3697988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of growth capacity of cells in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites.
    Fidler IJ; Li LM; Ananthaswamy HN; Esumi N; Radinsky R; Price JE
    Anticancer Res; 1991; 11(1):17-24. PubMed ID: 2018350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
    Douvdevani A; Huleihel M; Segal S; Apte RN
    Eur Cytokine Netw; 1991; 2(4):257-64. PubMed ID: 1756231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased retinoylation in NIH 3T3 cells transformed with activated Ha-ras.
    Takahashi N; De Luca LM; Breitman TR
    Biochem Biophys Res Commun; 1997 Oct; 239(1):80-4. PubMed ID: 9345273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts.
    Merzak A; Dooghe Y; Pironin M; Perbal B; Vigier P
    Oncogene; 1992 Oct; 7(10):2031-9. PubMed ID: 1408144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.